9th Circuit: Court Must Say Why FDA Can Withhold Ebola Drug Documents

Mealey's (March 31, 2020, 9:03 AM EDT) -- SAN FRANCISCO — The Ninth Circuit U.S. Court of Appeals on March 24 reversed summary judgment that denied access to Food and Drug Administration records about ZMapp, an experimental drug to treat the Ebola virus (Goldwater Institute v. U.S. Department of Health and Human Services, No. 19-15615, 9th Cir., 2020 U.S. App. LEXIS 9126)....

Attached Documents

Related Sections